CYCLANDELATE IN DIABETIC NEUROPATHY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, CROSS-OVER STUDY

被引:0
|
作者
HEIMANS, JJ [1 ]
DRUKARCH, B [1 ]
MATTHAEI, I [1 ]
IJFF, GA [1 ]
BERTELSMANN, FW [1 ]
STRIJERS, RLM [1 ]
NAUTA, J [1 ]
机构
[1] FREE UNIV AMSTERDAM HOSP,DEPT THEORY MED,1007 MB AMSTERDAM,NETHERLANDS
来源
ACTA NEUROLOGICA SCANDINAVICA | 1991年 / 84卷 / 06期
关键词
DIABETIC NEUROPATHY; THERAPY; CYCLANDELATE;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cyclandelate has the ability to improve the rheological properties of the blood and therefore may improve blood supply of peripheral nerves. Previous studies in diabetic neuropathy have shown beneficial effects of the drug. We performed a double-blind, placebo-controlled, cross-over study in 40 diabetic patients with cyclandelate in a dose of 1600 mg daily. Motor and sensory nerve conduction velocities, late responses, thermal discrimination thresholds, vibration perception thresholds and pain scores were studied. We were not able to show any positive effect of the drug and therefore conclude that cyclandelate is not effective in the treatment of diabetic neuropathy.
引用
收藏
页码:483 / 486
页数:4
相关论文
共 50 条
  • [31] A PLACEBO-CONTROLLED DOUBLE-BLIND-STUDY OF EPALRESTAT (ONO-2235) IN PATIENTS WITH DIABETIC NEUROPATHY
    GOTO, Y
    HOTTA, N
    SHIGETA, Y
    SAKAMOTO, N
    KITO, S
    MATSUOKA, K
    TAKAHASHI, A
    KIKKAWA, R
    SAKUMA, A
    DIABETIC MEDICINE, 1993, 10 (05) : S39 - S43
  • [32] Antioxidants for Pancreatic Functions in Chronic Pancreatitis A Double-blind Randomized Placebo-controlled Pilot Study
    Singh, Namrata
    Ahuja, Vineet
    Sachdev, Vikas
    Upadhyay, Ashish D.
    Goswami, Ravinder
    Ramakrishnan, Lakshmy
    Dwivedi, Supriya
    Saraya, Anoop
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2020, 54 (03) : 284 - 293
  • [33] A randomized, double-blind, placebo-controlled study of oral hydrolytic enzymes in relapsing multiple sclerosis
    Baumhackl, U
    Kappos, L
    Radue, EW
    Freitag, P
    Guseo, A
    Daumer, M
    Mertin, J
    MULTIPLE SCLEROSIS JOURNAL, 2005, 11 (02) : 166 - 168
  • [34] Treatment of Comorbid Migraine and Temporomandibular Disorders: A Factorial, Double-Blind, Randomized, Placebo-Controlled Study
    Goncalves, Daniela A. G.
    Camparis, Cinara M.
    Speciali, Jose G.
    Castanharo, Sabrina M.
    Ujikawa, Liliana T.
    Lipton, Richard B.
    Bigal, Marcelo E.
    JOURNAL OF OROFACIAL PAIN, 2013, 27 (04): : 325 - 335
  • [35] Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial
    Jagasia, M. H.
    Abonour, R.
    Long, G. D.
    Bolwell, B. J.
    Laport, G. G.
    Shore, T. B.
    Durrant, S.
    Szer, J.
    Chen, M-G
    Lizambri, R.
    Waller, E. K.
    BONE MARROW TRANSPLANTATION, 2012, 47 (10) : 1350 - 1355
  • [36] Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
    Goadsby, Peter J.
    Wietecha, Linda A.
    Dennehy, Ellen B.
    Kuca, Bernice
    Case, Michael G.
    Aurora, Sheena K.
    Gaul, Charly
    BRAIN, 2019, 142 : 1894 - 1904
  • [37] Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy: A long-term, randomised, double-blind, placebo-controlled study
    De Grandis D.
    Minardi C.
    Drugs in R & D, 2002, 3 (4) : 223 - 231
  • [38] A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis
    Pariser, Robert J.
    Paul, Joan
    Hirano, Stefanie
    Torosky, Cyndi
    Smith, Molly
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (05) : 765 - 773
  • [39] Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial
    Webb, David J.
    Coll, Blai
    Heerspink, Hiddo J. L.
    Andress, Dennis
    Pritchett, Yili
    Brennan, John J.
    Houser, Mark
    Correa-Rotter, Ricardo
    Kohan, Donald
    Makino, Hirofumi
    Perkovic, Vlado
    Remuzzi, Giuseppe
    Tobe, Sheldon W.
    Toto, Robert
    Busch, Robert
    Pergola, Pablo
    Parving, Hans-Henrik
    de Zeeuw, Dick
    DRUGS IN R&D, 2017, 17 (03) : 441 - 448
  • [40] Chronic cough and esomeprazole: A double-blind placebo-controlled parallel study
    Faruqi, Shoaib
    Molyneux, Ian D.
    Fathi, Hosnieh
    Wright, Caroline
    Thompson, Rachael
    Morice, Alyn H.
    RESPIROLOGY, 2011, 16 (07) : 1150 - 1156